MedTrace Logo

PDA Post NICU Discharge

NCT02750228 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 208

Last updated 2020-06-30

No results posted yet for this study

Summary

The purpose of this study is to track post-discharge outcomes on prematurely born infants who are discharged from the NICU with a patent ductus arteriosus (PDA). Investigators plan to report on the spontaneous closure rate as well as the incidence of pulmonary and/or cardiac events in these infants. The goal is to identify risk factors associated with adverse outcomes in prematurely born infants who are sent home with a PDA.

Conditions

  • Patent Ductus Arteriosus

Sponsors & Collaborators

  • Pediatrix

    lead OTHER

Eligibility

Min Age
22 Weeks
Max Age
32 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2020-06-30
Completion
2020-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02750228 on ClinicalTrials.gov